Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
about
X-ray crystallography over the past decade for novel drug discovery - where are we heading next?Influenza treatment and prophylaxis with neuraminidase inhibitors: a reviewA Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 HemagglutininInfluenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological ActivityNew small-molecule drug design strategies for fighting resistant influenza ACompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusThe future of crystallography in drug discovery.From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?Recent progress and challenges in the discovery of new neuraminidase inhibitors.A virtual screening approach for identifying plants with anti H5N1 neuraminidase activity.Neuraminidase of Influenza A Virus Binds Lysosome-Associated Membrane Proteins Directly and Induces Lysosome Rupture.Synthetic Mucus Nanobarriers for Identification of Glycan-Dependent Primary Influenza A Infection Inhibitors.Antiviral strategies against influenza virus: towards new therapeutic approaches.A review of neuraminidase inhibitor susceptibility in influenza strains.The chemistry and biology of guanidine natural products.Antiviral effects of Yinhuapinggan granule against influenza virus infection in the ICR mice model.The hydrophobic side chain of oseltamivir influences type A subtype selectivity of neuraminidase inhibitors.Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection.Fullerene-sp2-iminosugar balls as multimodal ligands for lectins and glycosidases: a mechanistic hypothesis for the inhibitory multivalent effect.An atom-economic approach to carboxylic acids via Pd-catalyzed direct addition of formic acid to olefins with acetic anhydride as a co-catalyst.#Nitrosocarbonyls 1: antiviral activity of N-(4-hydroxycyclohex-2-en-1-yl)quinoline-2-carboxamide against the influenza A virus H1N1.Synthesis of oseltamivir and tamiphosphor from N-acetyl-d-glucosamine
P2860
Q26801307-CC089BB0-C460-4832-9782-E917B18C3788Q26860032-AFFF1A51-E9B7-431C-8819-728CBA107E3DQ27679987-EC30F6B5-C303-42BB-BACD-440C51A7D696Q28079041-A8896670-8FC0-47F5-B133-1F5450952F4CQ28080554-D2E7A70A-0C67-4790-85B6-6C9254B605E8Q28084005-835A59B5-5C77-4B26-8C73-120E3FB499B0Q28655467-89A530C0-C0CE-433B-9405-0BE4EF37AD2BQ30363724-0F0AABBB-FFE2-4BE3-B6E7-990D5B0425C7Q30426630-7BC349AE-F40B-443E-BA2D-3A1DDBE540F6Q35121118-8C80C903-8E96-48B4-883D-91EF23A46297Q36086233-4CD41F30-5B9B-4953-A9A3-1556FFA1E8BAQ37374096-C71218A6-CD9A-47ED-9B4C-246FC910791BQ38202012-3AC1EEE9-D1D6-4B95-8F3F-C20AC00CF46EQ38258646-A9C33F1C-F5FE-4A40-960C-13B308F7E25CQ38675089-2850FF80-260A-4531-BDAD-622D738B172EQ40136193-98F71D09-6556-4942-8025-4BC3A8C3BD15Q40147214-C2F9D7F0-EDCC-4DD9-A9D3-13EB0EC75DA4Q42274102-BC7FE4E7-D05D-464C-BB0A-EF5E1B1807A2Q44953389-8B20219F-53C6-4BC9-BAAE-C07C4C64A8FDQ53182606-55365BFC-1176-4656-9F7C-E93ECC439877Q55619780-C309CDC6-1222-427D-851D-DF704640B74AQ58239503-9A411205-ADAE-4DC2-AF80-98040507EF96
P2860
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
@ast
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
@en
type
label
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
@ast
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
@en
prefLabel
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
@ast
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
@en
P2093
P2860
P356
P1433
P1476
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
@en
P2093
Dengyou Zhang
Enguang Feng
Hualiang Jiang
Jinfang Wang
Mingyue Zheng
P2860
P304
P356
10.1002/CMDC.201200155
P577
2012-07-16T00:00:00Z